What condition is characterized by dysfunction of peroxisome proliferator-activated receptors?

Prepare for the NBME Form 29 Test. Study with interactive flashcards and detailed multiple-choice questions, each with explanations and tips. Achieve success on your exam!

Multiple Choice

What condition is characterized by dysfunction of peroxisome proliferator-activated receptors?

Explanation:
Type 2 Diabetes Mellitus is closely associated with the dysfunction of peroxisome proliferator-activated receptors (PPARs). PPARs are a group of nuclear receptor proteins that play essential roles in regulating glucose and lipid metabolism and are involved in inflammation and cellular differentiation. Specifically, PPAR-gamma, one of the most studied subtypes, helps to improve insulin sensitivity in adipose tissue and plays a crucial role in fatty acid storage and glucose metabolism. In Type 2 Diabetes, the effectiveness of insulin is reduced, leading to impaired glucose uptake and increased blood glucose levels. Dysfunction in PPARs, particularly PPAR-gamma, can further exacerbate insulin resistance, contributing to the pathophysiology of Type 2 Diabetes. This is why medications that act as PPAR-gamma agonists, such as thiazolidinediones, can improve insulin sensitivity in individuals with this condition. While other types of diabetes and hyperthyroidism are indeed related to metabolic processes, they do not primarily involve the specific dysfunction of PPARs as a central mechanism in their pathogenesis.

Type 2 Diabetes Mellitus is closely associated with the dysfunction of peroxisome proliferator-activated receptors (PPARs). PPARs are a group of nuclear receptor proteins that play essential roles in regulating glucose and lipid metabolism and are involved in inflammation and cellular differentiation. Specifically, PPAR-gamma, one of the most studied subtypes, helps to improve insulin sensitivity in adipose tissue and plays a crucial role in fatty acid storage and glucose metabolism.

In Type 2 Diabetes, the effectiveness of insulin is reduced, leading to impaired glucose uptake and increased blood glucose levels. Dysfunction in PPARs, particularly PPAR-gamma, can further exacerbate insulin resistance, contributing to the pathophysiology of Type 2 Diabetes. This is why medications that act as PPAR-gamma agonists, such as thiazolidinediones, can improve insulin sensitivity in individuals with this condition.

While other types of diabetes and hyperthyroidism are indeed related to metabolic processes, they do not primarily involve the specific dysfunction of PPARs as a central mechanism in their pathogenesis.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy